Genesis Launches 50-Cancer Detection Test in Brazil

Genesis is introducing its multi-cancer early detection test to the Brazilian market, expanding access to a screening tool that detects 50 cancer types from a blood sample. The move signals growing adoption of liquid biopsy technology in emerging markets, though regulatory and reimbursement details remain unclear. This could shift cancer screening paradigms in Brazil, but clinical utility and cost-effectiveness are yet to be fully established.